ArticlePhysics and imaging in radiation oncology2025
Comparison of stereotactic photon and proton treatment plans for metastasis-directed radiotherapy.
Article in Physics and imaging in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: Achieving optimal local control is pivotal in the context of metastasis-directed therapy (MDT) in delaying further metastatic spread. The clear correlation between the biological equivalent dose (BED) and local control, with rates reaching 99 % when BED exceeds 100 Gy using an α:β ratio of 3, underlines the importance of investigating advanced radiation modalities. Materials & methods: A planning study was conducted in 20 patients treated for 38 lesions to compare photon based and proton based stereotactic radiation therapy in oligoprogressive metastatic castration-refractory prostate cancer patients. The primary objective was to determine whether proton therapy is achieving a satisfactory BED Results: Volumetric Modulated Arc Therapy (VMAT) and Intensity Modulated Proton Therapy (IMPT) achieved a satisfactory BED Conclusion: Proton therapy may reduce long-term treatment-related toxicities and be more effective for re-irradiation. It achieves a satisfactory BED
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.